Background: The prevalence of ampicillin-and/or vancomycin-resistant Enterococcus faecium (AREf and VREf) has increased in hospitalized patients in the Netherlands.
Introduction
Enterococcus spp. are commensals of the gastrointestinal tract of humans, 1 but also have the ability to infect humans. 2 Enterococcus faecium has been noted for its antimicrobial resistance since the 1970s. 2 High-level resistance to ampicillin and vancomycin emerged in hospitals in the United States in the 1980s and 1990s, respectively, resulting in an increasing number of healthcare-associated infections and outbreaks caused by E. faecium strains resistant to both ampicillin and vancomycin, [3] [4] [5] although colonization was not observed in the general community. 6 In 2007, .80% of E. faecium isolates from hospitalized patients in the United States were resistant to vancomycin. 7 In Europe, the prevalence of vancomycin-resistant E. faecium (VREf) in hospitals was still low (3%) in the 1990s, whereas VREf (but not ampicillin-resistant E. faecium; AREf) carriage rates in the community and meat products in this decade were high (8% in humans and up to 100% in poultry). 6, 8 In Europe, the vancomycin analogue avoparcin was used until 1997 as antimicrobial growth promoter resulting in high VREf rates in animal husbandry and in the general population. 6 After the ban on avoparcin use in 1997, VREf colonization rates in the general population decreased. 6 VREf infections in hospitalized patients are associated with severe health outcomes, longer length of stay and higher healthcare costs. 9, 10 Between 2012 and 2015, 44 hospital outbreaks with VREf occurred in the Netherlands. 11 Despite the high number of hospital outbreaks, proportions of VREf among clinical cultures yielding enterococci in Dutch laboratories in 2015 were 0.7% (5 of 761 tested isolates) in ICUs, 1.0% (22 of in inpatient departments (excluding ICUs), 0.9% (4 of 435 tested isolates) in outpatient departments and 0.7% (2 of 293 tested isolates) in general practices. 11 Although the community was considered a potential source of AREf and VREf in the Netherlands, 6 the current prevalence and risk factors of AREf and VREf in humans and pets in the general community have remained largely unknown. Damborg et al. 12 found AREf in 42 of the 183 (23%) dogs screened in the UK in 2006. Among 25 dogs evaluated longitudinally in Denmark, 19 (76%) had at least one positive sample during the study in 2007. In 2008 however, only 2 of 127 (1.6%) dogs were AREf positive in Denmark. Using MLST, the majority of dog isolates clustered with the hospital-associated AREf clonal complex 17 (CC17), supporting the hypothesis of AREf transmission between hospitals and the community. 13 In the Netherlands, VREf were not detected in rectal swabs of 100 dogs visiting an animal clinic in 2002.
14 However, in 2012, VREf prevalence in rectal swabs was 30% for dogs, 13% for cats and 8% for non-hospitalized humans receiving amoxicillin. 15 In light of these findings and the continuous occurrence of AREf infections and VREf outbreaks in Dutch hospitals we aimed to quantify the co-carriage of AREf and VREf in humans, cats and dogs in the Dutch population.
Methods

Study design and epidemiological data collection
From November 2014 to November 2015, a cross-sectional study was performed among Dutch residents. During the study period, each month a random sample (including all age groups) of 2000 residents in the Netherlands was drawn from municipal population registries covering the whole Dutch population (17 million inhabitants), stratified by geographical region and degree of urbanization. Only one person per household was included in the study and invited by regular mail [Invitation letter S1 (adults; the invitation letter was almost the same for the children), available as Supplementary data at JAC Online] to complete a web-based questionnaire. The option to fill out the questionnaire with the help of a third party (for example, a family member, healthcare worker or neighbour) was provided. The inclusion of children occurred in the same way as the adults, with the difference that for children aged 0-12 years a parent or caregiver filled out the questionnaire. Children aged 13-17 years could fill out the questionnaire themselves, however the parent was allowed to help.
Faecal sample collection
Upon completion of the first questionnaire, all participants were asked to provide a faecal sample, and, if there was a dog or cat in the household, also from one dog or cat. If willing to submit a faecal sample, a stool sample collection kit was provided, containing one or two (depending on whether the participant also wanted to provide a sample from a pet) pre-labelled sterile tube(s) for faecal sample collection. Additionally, a short second web-based questionnaire was introduced with similar questions as the first, but referring to the 4 weeks prior to the faecal sample collection.
Questionnaires
The first web-based questionnaire addressed questions about the level of education, the use of medication [antibiotics, proton pump inhibitors (PPIs), blood pressure-lowering drugs, tranquillizers, cholesterol-lowering drugs and antidiabetic drugs in the past 6 months], hospitalization of the interviewee and hospitalization of a household member in the past 12 months (one night or more), travelling abroad in the past 12 months prior to questionnaire completion and having animals in or around the home. For pets, similar questions were included: antibiotic usage, hospitalization or visiting a veterinary doctor, having health complaints, predation, coprophagy (in the case of a dog only: ingestion of faeces, either their own or from other animals), eating of raw meat, travelling abroad, staying in a kennel and having contact with other animals. The questionnaire was based on questionnaires used in previous studies. [16] [17] [18] [19] [20] Moreover, the questionnaire was pre-tested by epidemiologists, and thereafter in a small group of nonprofessionals. Finally, we also tested the questionnaire during 1 month in the general population, also to pilot our logistics. During all these steps the questions were reduced, simplified and categories changed, which resulted in the final questionnaire (Questionnaire S1).
In the second questionnaire, some of the questions from the first questionnaire were repeated to ensure up-to-date information and additional questions were asked about contact with animals, antibiotic use in the 4 weeks prior to faecal sample collection and eating of raw or undercooked meat in the week prior to faecal sample collection (Questionnaire S2). We sent reminders to the participants after 10 and after 20 days in the case of no response.
Microbiology and genotyping
The human, dog and cat faecal samples were analysed for the presence of AREf and VREf by inoculating two different Enterococcosel broths, one with 12 mg/L aztreonam and 16 mg/L ampicillin, to detect AREf isolates, and the other with 12 mg/L aztreonam and 4 mg/L vancomycin for the detection of VREf. Both were incubated for 48 h at 37 C. In the case of growth in the Enterococcosel broth for AREf detection, the sample was inoculated on Enterococcosel Enrichment Agar with ampicillin (16 mg/L). In the case of growth in the Enterococcosel broth for VREf detection, the sample was inoculated on Enterococcosel Enrichment Agar with vancomycin (4 mg/L). Both were incubated for 48 h. Subsequently, five colonies were plated on blood agar plates and in the case of different morphologies, speciation was performed on every morphology by MALDI-TOF. The presence of vanA and vanB genes was determined by PCR as described earlier by Dutka-Malen et al.
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For WGS, genomic DNA was prepared using the Wizard Genomic DNA Purification kit (Promega, Leiden, The Netherlands) according to the manufacturer's instructions. Barcoded paired-end libraries were created for each isolate with 1 ng of DNA using the Nextera XT DNA sample preparation kit (Version C protocol; Illumina). Amplicons .500 bp were size selected in the post-PCR purification steps. The Nextera XT libraries were sequenced on a 150PE NextSeq (Illumina) run. Quality trimming of the reads was performed using the seqtk 1.0-r82-dirty (Heng Li, 2012, https://github.com/lh3/seqtk) trimfq option with default parameters. Assembly of these trimmed reads was then obtained using SPAdes 3.6.2 with the options-only-assemblercareful-threads 8. 22 Scaffolds 500 bp were removed from the assembly.
The assemblies were uploaded in SeqSphere ! version 3.5.0 (Ridom GmbH, Münster, Germany; http://www.ridom.de/seqsphere/) to determine the allelic profiles using the core genome MLST (cgMLST) scheme for E. faecium. 23 Allelic profiles of the strains of this study are available at http://www.cgmlst.org/ncs/schema/991893/ and in Table S1 . Strains with 20 allele differences are considered clonally related according to de Been et al. 23 A neighbour joining tree was generated based on the cgMLST data of the isolates in Microreact (http://microreact.org). 24 
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Statistical analyses
Data were assumed to be missing at random, and therefore missing data were imputed by imputing and pooling 10 imputations as described by van Buuren and Groothuis-Oudshoorn. 25 Logistic regression analyses were performed to identify factors associated with AREf carriage in humans and in their dogs, separately. A total of 23, 14 and 13 putative risk factors for AREf carriage were first explored in humans, dogs and cats respectively. Variables with P 0.25 in univariate analyses were included in multivariate models. Age was included as a control covariate in the multivariate model for humans. Multivariate model selection was based on Akaike information criteria. Covariates were considered to be a risk factor for AREf carriage if P , 0.05 in the model. Potential confounding effects were studied by adding those to the final model; when they changed the established risk factors by 10% the variable was considered a confounder of the effect between the outcome of AREf occurrence and the determinant and included in the final model. Interactions between independent variables were tested and if an interaction term was statistically significant (P , 0.05), the interaction term was added to the final model. Associations were expressed as ORs and corresponding 95% CIs.
Internal validation by bootstrapping (10 000 replications) of the imputed, final multiple logistic regression models were performed to crossvalidate the models. 26 Bootstrapped ORs and bias-corrected bootstrap 95% CIs were calculated. As sensitivity analyses we also performed complete case analyses. For these analyses, we also computed the bootstrapped ORs and the bias-corrected bootstrap 95% CIs (10000 replications). All multivariable models showed an overall statistical significance (likelihood-ratio v 
Results
In total, 25365 subjects were invited, of which 4721 (18.6%) completed the questionnaire; from these, 1992 (42.2%) human and 395 pet (277 dog and 118 cat) faecal samples were submitted. Seven participants provided only a pet sample; 388 pet owners provided both a human and animal stool sample (269 human ! dog, 115 human ! cat, 4 human ! unknown). The median transport time of the faecal samples by regular mail was 1 day (IQR 1-2 days). The median age of human participants was 56 years (IQR 40-66 years) and 890 were male (44.7%). Reported antimicrobial use in the 8 weeks before sample collection was 7.3% (n " 135) in humans, 7.2% (n " 18) for dogs and 7.9% (n " 8) for cats. Hospitalization in the 4 weeks prior to submitting the faecal sample was reported by 14 humans (0.8%) and 156 (7.9%) reported hospitalization (one night or more) in the year before sample collection. Animals were kept in 963 households (48.8%); 132 households owned both a cat and a dog (6.7%), with 327 (16.6%) owning a dog and 284 a cat (14.4%). General baseline characteristics for humans, dogs and cats are presented in Tables 1 and 2 .
Prevalence
All faecal samples were screened for AREf and VREf. AREf was detected in 29 human samples (1.5%, 95% CI 1.0%-2.1%), 71 dogs (25.6%, 95% CI 20.8%-31.1%) and 6 cats (5.1%, 95% CI 2.4%-10.7%). There was no evidence of regional clustering of AREf carriage at the municipality level (Figure 1) . VREf (vanA genes) was detected in one human and one dog sample. The VREf-positive human was a non-hospitalized male using an antibiotic (cefaclor) at the time of faecal sample collection. The VREf-carrying dog had no reported antibiotic use in the 6 months prior to sample collection. AREf or VREf co-carriage in the human-pet pairs from the same household was not observed.
Risk factors for AREf carriage in humans
In a multivariate model for AREf carriage in humans, antibiotic use (Table S2 ) within 8 weeks prior to sample collection (OR 4.2, 95% CI 1.7-11.2) and the use of PPIs within 6 months prior to sample collection (OR 2.7, 95% CI 1.1-6.3) appeared to be risk factors for AREf carriage. Other potential confounders and effect modifiers did not meet the criteria for inclusion in the models (Table 3 ). Sensitivity analysis of complete case records hardly changed associations; the OR was 4.0 (95% CI 1.4-10.6) for antibiotic usage within 8 weeks prior to sample collection and 2.4 (95% CI 1.0-6.0) for prior use of PPIs.
Risk factors for AREf carriage in dogs
In dogs the use of antibiotics in the past 6 months (OR 2.3, 95% CI 1.1-4.6) and eating raw meat (OR 3.2, 95% CI 1.4-6.6) appeared to be risk factors for AREf carriage. There were no identified confounders or effect modifiers (Table 4 ). In the complete case analysis, the same risk factors remained in the final model. As there were only six AREf-positive cats no risk factor analysis was performed.
Molecular characterization and analyses
Blood agar plates did not show any differences in morphology between colonies. Besides E. faecium, Enterococcus faecalis was also observed in eight isolates (one was ampicillin resistant). Other species detected by MALDI-TOF were Enterococcus casseliflavus (51 isolates), Enterococcus gallinarum (26 isolates), Enterococcus raffinosus (1 isolate) and Enterococcus avium (1 isolate).
cgMLST was performed on 30 human (29 AREf isolates and 1 VREf isolate) and 80 pet E. faecium isolates [71 AREf isolates from dogs, 6 from cats and 2 from unknown (dog or cat), and 1 VREf isolate from a dog]. A phylogenetic tree based on cgMLST data revealed considerable genetic diversity among the human and pet isolates, but also clusters of closely related isolates. No host-specific clusters were observed, although 10 clusters contained both human and pet isolates with allelic variation in 9-212 cgMLST genes ( Figure 2 , Table S1 ). In 3 of the 10 clusters the genotypic difference between human and dog isolates ranged between 13 and 20 loci, which is below the threshold of 20 allele differences for clonally related strains as determined by de Been et al. 23 These clusters included cluster 2 (2 human, 4 pet isolates), cluster 7 (1 human, 14 pet isolates) and cluster 8 (2 human, 1 pet isolates). In total, 5 (16.7%) of the human isolates were clonally related, with 20 allele differences, to 19 (23.8%) pet isolates. There was no correlation in geographic origin among the isolates within the clusters.
Discussion
In this large countrywide population-based study the prevalence of intestinal carriage of AREf was 1.5% in the general human population, 25.6% in dogs and 5.1% in cats. VREf was detected in one human subject and in one dog. Risk factors for AREf carriage were prior antibiotic use and PPI use in humans, and prior antibiotic use AREf and VREf in the Dutch community JAC Table 2 . Descriptive statistics for dogs and cats van den Bunt et al.
and eating of raw meat in dogs. Co-carriage of AREf or VREf between pet owners and pets was not observed. Using 20 allele differences in cgMLST as the cut-off for clonal relatedness, 23 16.7% of the human and 23.8% of the pet isolates were clonally related, suggesting that only the minority of human and pet isolates are epidemiologically linked. Hospitalization in the year prior sampling was less prevalent in the AREf-positive group (1 of 29, 3.4%) than in the AREf-negative group (155 of 1957, 7.9%) indicating that hospitalization was not a risk factor for AREf/VREf carriage in this study. Our finding that antibiotic use is a risk factor for AREf carriage confirms results from previous studies. 4, 27, 28 Moreover, we observed the use of PPIs as a risk factor for AREf carriage as well, which adds to reported associations between PPI use and VREf carriage in liver transplant candidates 29 and with intestinal carriage of Enterobacteriaceae producing ESBL in hospitalized patients in the Netherlands. [30] [31] [32] Suppression of gastric acid production may reduce the natural barrier function of intragastric acidity against ingested bacteria. Considering the large-scale use of PPIs, 33 the role of PPIs in relation to the selection of antibiotic-resistant bacteria should be more extensively investigated.
The prevalence of AREf in cats and dogs in this study is in agreement with earlier studies in the Netherlands in which 30% of dogs (24 of 79) and 13% (11 of 85) of cats were colonized with AREf. AREf and VREf in the Dutch community JAC Similar findings have been reported in the UK and Denmark, where in 2006-07, prevalences in dogs were 23% and 76%, respectively. 13 Eating raw meat was identified as a risk for AREf carriage in dogs. In addition, VREf contamination of raw meat in retail outlets has been reported in Italy in 2002, with 29% of raw meat sold in retail outlets being contaminated, 34 and in the UK, with 18.5% of raw chicken meat being contaminated. 35 In contrast, in a Canadian study, performed in 2008, the eating of raw meat by dogs was associated with the shedding of Salmonella and extended-spectrum cephalosporinase-positive Escherichia coli, but not of MRSA, VREf or Clostridium difficile. 36 The results in this study do not indicate frequent transmission of AREf between humans and pets as: (i) we did not observe any co-carriage in human and pet pairs belonging to the same household; (ii) having dogs or cats in the household was not a risk factor for AREf carriage in humans; and (iii) phylogenetic analysis revealed genetic relatedness of isolates in only a minority of human and pet isolates. Models are performed after multiple imputation (n " 10). Cluster Figure 2 . Phylogenetic tree of ARE-and VRE-positive human and pet isolates originating from the Dutch community. Maximum allele difference is given if the isolates originating from pets were co-located in the same lineage. We identified 10 clusters, of which clusters 2, 7 and 8 were clonally related (Table S1 ). Two VRE isolates are also included in this figure. van den Bunt et al.
Study limitations include the-unavoidable-possibility of residual confounding, selection bias among study participants and recall bias for activities and behaviour in the past. The response rate of 18.6% though was comparable with other Dutch studies in which participants were approached for submitting faecal samples.
17, 32 We used web-based questionnaires, which might be less accessible for the elderly; however, in the Netherlands, 97.1% of inhabitants have access to internet. 37 In addition, we also provide the option to fill out the questionnaire with the help of a third party (for example, a family member, healthcare worker or neighbour). Moreover, as we were aware of this possible risk, we selected relatively more subjects of elderly age, to be able to give a good estimate of AREf/VREf carriage in elderly persons.
Despite the large study setup, with 25 365 subjects being invited, the prevalence of VREf carriage in humans, dogs and cats and AREf carriage in cats was too low for risk factor analysis.
In conclusion, intestinal carriage of AREf or VREf is rare in the Dutch general population. Although AREf carriage is high in pets, particularly in dogs, phylogenetic linkage between human and pet AREf isolates was limited.
